The subfornical organ: A novel site of action of cholecystokinin

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 306, Issue 5, 2014, Pages

  Ahmed, Al Shaimaa F ^a   Dai, Li ^b   Ho, Winnie ^a   Ferguson, Alastair V ^b   Sharkey, Keith A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

c Fos; CCK antagonists; Electrophysiology; Immunohistochemistry; p ERK; Vagus

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE; PROTEIN C FOS; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; CHOLECYSTOKININ; CHOLECYSTOKININ RECEPTOR; HORMONE ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE FRAGMENT; RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DEPOLARIZATION; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOLITARY TRACT NUCLEUS; SUBFORNICAL ORGAN; ANIMAL; C-FOS; CCK-ANTAGONISTS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ONCOGENE; P-ERK; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VAGUS NERVE;

C-FOS; CCK-ANTAGONISTS; ELECTROPHYSIOLOGY; IMMUNOHISTOCHEMISTRY; P-ERK; VAGUS;

ANIMALS; BENZODIAZEPINONES; CHOLECYSTOKININ; DEVAZEPIDE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; GENES, FOS; HORMONE ANTAGONISTS; MALE; NEURONS; PEPTIDE FRAGMENTS; PHENYLUREA COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; RNA; SUBFORNICAL ORGAN;

EID: 84899413068     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00462.2013     Document Type: Article

References (89)

1. Alim I, Fry WM, Walsh MH, Ferguson AV. Actions of adiponectin on the excitability of subfornical organ neurons are altered by food deprivation. Brain Res 1330: 72-82, 2010.
2. Anthes N, Schmid HA, Hashimoto M, Riediger T, Simon E. Heterogeneous actions of vasopressin on ANG II-sensitive neurons in the subfornical organ of rats. Am J Physiol Regul Integr Comp Physiol 273: R2105-R2111, 1997.
3. Babic T, Townsend RL, Patterson LM, Sutton GM, Zheng H, Berthoud HR. Phenotype of neurons in the nucleus of the solitary tract that express CCK-induced activation of the ERK signaling pathway. Am J Physiol Regul Integr Comp Physiol 296: R845-R854, 2009.
4. Baptista V, Browning KN, Travagli RA. Effects of cholecystokinin-8s in the nucleus tractus solitarius of vagally deafferented rats. Am J Physiol Regul Integr Comp Physiol 292: R1092-R1100, 2007.
5. Brenner L, Yox DP, Ritter RC. Suppression of sham feeding by intraintestinal nutrients is not correlated with plasma cholecystokinin elevation. Am J Physiol Regul Integr Comp Physiol 264: R972-R976, 1993.
6. Campos CA, Wright JS, Czaja K, Ritter RC. CCK-induced reduction of food intake and hindbrain MAPK signaling are mediated by NMDA receptor activation. Endocrinology 153: 2633-2646, 2012.
7. Cano V, Caicoya E, Ruiz-Gayo M. Effect of peripheral cholecystokinin receptor agonists on c-Fos expression in brain sites mediating food consumption in rats. Neurosci Lett 343: 13-16, 2003.
8. Chen DY, Deutsch JA, Gonzalez MF, Gu Y. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718. Neurosci Lett 149: 91-94, 1993.
9. Chen H, Kent S, Morris MJ. Is the CCK2 receptor essential for normal regulation of body weight and adiposity? Eur J Neurosci 24: 1427-1433, 2006.
10. Chung L, Moore SD. Cholecystokinin enhances GABAergic inhibitory transmission in basolateral amygdala. Neuropeptides 41: 453-463, 2007.
11. Dabrowski A, Detjen KM, Logsdon CD, Williams JA. Stimulation of both CCK-A and CCK-B receptors activates MAP kinases in AR42J and receptor-transfected CHO cells. Digestion 58: 361-367, 1997.
12. Dai L, Smith PM, Kuksis M, Ferguson AV. Apelin acts in the subfornical organ to influence neuronal excitability and cardiovascular function. J Physiol 591: 3421-3432, 2013.
13. Dellmann HD, Simpson JB. Regional differences in the morphology of the rat subfornical organ. Brain Res 116: 389-400, 1976.
14. Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29: 261-265, 1989.
15. Dufresne M, Seva C, Fourmy D. Cholecystokinin and gastrin receptors. Physiol Rev 86: 805-847, 2006.
16. Duvernoy HM, Risold PY. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev 56: 119-147, 2007.
17. Ehrlich KJ, Fitts DA. Atrial natriuretic peptide in the subfornical organ reduces drinking induced by angiotensin or in response to water deprivation. Behav Neurosci 104: 365-372, 1990.
18. Ervin GN, Birkemo LS, Johnson MF, Conger LK, Mosher JT, Menius JA Jr. The effects of anorectic and aversive agents on deprivation-induced feeding and taste aversion conditioning in rats. J Pharmacol Exp Ther 273: 1203-1210, 1995.
19. Eysselein VE, Eberlein GA, Hesse WH, Singer MV, Goebell H, Reeve JR Jr. Cholecystokinin-58 is the major circulating form of cholecystokinin in canine blood. J Biol Chem 262: 214-217, 1987.
20. Ferguson A, Bains J, Lowes V. Circumventricular organs and cardiovascular homeostasis. In: Central Neural Mechanisms in Cardiovascular Regulation, edited by Kunos G and Ciriello J. Boston, MA: Birkhäuser, 1992, p. 80-101.
21. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: implications for long term control of autonomic output. Clin Exp Pharmacol Physiol 24: 96-101, 1997.
22. Ferguson AV, Bicknell RJ, Carew MA, Mason WT. Dissociated adult rat subfornical organ neurons maintain membrane properties and angiotensin responsiveness for up to 6 days. Neuroendocrinology 66: 409-415, 1997.
23. Folsch UR, Cantor P, Wilms HM, Schafmayer A, Becker HD, Creutzfeldt W. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology 92: 449-458, 1987.
24. Fraser KA, Davison JS. Cholecystokinin-induced c-fos expression in the rat brain stem is influenced by vagal nerve integrity. Exp Physiol 77: 225-228, 1992.
25. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 27: 422-427, 2000.
26. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
27. Glatzle J, Raybould HE, Kueper MA, Reeve JR Jr, and Zittel TT. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats. Nutr Neurosci 11: 69-74, 2008.
28. Goebel-Stengel M, Stengel A, Wang L, Ohning G, Tache Y, Reeve JR Jr. CCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed rats. Am J Physiol Regul Integr Comp Physiol 303: R850-R860, 2012.
29. Guijarro A, Suzuki S, Chen C, Kirchner H, Middleton FA, Nadtochiy S, Brookes PS, Niijima A, Inui A, Meguid MM. Characterization of weight loss and weight regain mechanisms after Roux-en-Y gastric bypass in rats. Am J Physiol Regul Integr Comp Physiol 293: R1474-R1489, 2007.
30. Gulley S, Sharma SK, Moran TH, Sayegh AI. Cholecystokinin-8 increases Fos-like immunoreactivity in the brainstem and myenteric neurons of rats through CCK1 receptors. Peptides 26: 1617-1622, 2005.
31. Houpt TA, Smith GP, Joh TH, Frankmann SP. c-fos-like immunoreactivity in the subfornical organ and nucleus of the solitary tract following salt intake by sodium-depleted rats. Physiol Behav 63: 505-510, 1998.
32. Hughes P, Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 47: 133-178, 1995.
33. Izzo RS, Brugge WR, Praissman M. Immunoreactive cholecystokinin in human and rat plasma: correlation of pancreatic secretion in response to CCK. Regul Pept 9: 21-34, 1984.
34. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J 7: 678-686, 1993.
35. Joyner K, Smith GP, Gibbs J. Abdominal vagotomy decreases the satiating potency of CCK-8 in sham and real feeding. Am J Physiol Regul Integr Comp Physiol 264: R912-R916, 1993.
36. Katanyutanon S, Wu R, Wang P. The effect of whole-body radiation on blood levels of gastrointestinal peptides in the rat. Int J Clin Exp Med 1: 332-337, 2008.
37. Kobelt P, Paulitsch S, Goebel M, Stengel A, Schmidtmann M, van der Voort IR, Tebbe JJ, Veh RW, Klapp BF, Wiedenmann B, Tache Y, Monnikes H. Peripheral injection of CCK-8S induces Fos expression in the dorsomedial hypothalamic nucleus in rats. Brain Res 1117: 109-117, 2006.
38. Koyama S, Fujita T, Uematsu H, Shibamoto T, Aibiki M, Kojima S. Inhibitory effect of renal nerve activity during canine anaphylactic hypotension. Am J Physiol Regul Integr Comp Physiol 258: R383-R387, 1990.
39. Lakhi S, Snow W, Fry M. Insulin modulates the electrical activity of subfornical organ neurons. Neuroreport 24: 329-334, 2013.
40. Li BH, Rowland NE. Cholecystokinin-and dexfenfluramine-induced anorexia compared using devazepide and c-fos expression in the rat brain. Regul Pept 50: 223-233, 1994.
41. Li Z, Ferguson AV. Angiotensin II responsiveness of rat paraventricular and subfornical organ neurons in vitro. Neuroscience 55: 197-207, 1993.
42. Lovick TA. CCK as a modulator of cardiovascular function. J Chem Neuroanat 38: 176-184, 2009.
43. MacLean DB. Abrogation of peripheral cholecystokinin-satiety in the capsaicin treated rat. Regul Pept 11: 321-333, 1985.
44. Mamoun AH, Bergstrom J, Sodersten P. Cholecystokinin octapeptide inhibits carbohydrate but not protein intake. Am J Physiol Regul Integr Comp Physiol 273: R972-R980, 1997.
45. McCutcheon B, Ballard M, McCaffrey RJ. Intraperitoneally injected cholecystokinin-octapeptide activates pica in rats. Physiol Behav 51: 543-547, 1992.
46. Mendelsohn FA, Quirion R, Saavedra JM, Aguilera G, Catt KJ. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA 81: 1575-1579, 1984.
47. Moran TH, Baldessarini AR, Salorio CF, Lowery T, Schwartz GJ. Vagal afferent and efferent contributions to the inhibition of food intake by cholecystokinin. Am J Physiol Regul Integr Comp Physiol 272: R1245-R1251, 1997.
48. Moran TH, Kinzig KP. Gastrointestinal satiety signals. II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 286: G183-G188, 2004.
49. Moran TH, McHugh PR. Cholecystokinin suppresses food intake by inhibiting gastric emptying. Am J Physiol Regul Integr Comp Physiol 242: R491-R497, 1982.
50. Moreau JM, Ciriello J. Nesfatin-1 induces Fos expression and elicits dipsogenic responses in subfornical organ. Behav Brain Res 250: 343-350, 2013.
51. Mosher JT, Birkemo LS, Johnson MF, Ervin GN. Sulfated cholecystokinin (26-33) induces mild taste aversion conditioning in rats when administered by three different routes. Peptides 19: 849-857, 1998.
52. Noetzel S, Stengel A, Inhoff T, Goebel M, Wisser AS, Bannert N, Wiedenmann B, Klapp BF, Tache Y, Monnikes H, Kobelt P. CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem. Regul Pept 157: 84-91, 2009.
53. Ogawa N, Ito M, Yamaguchi H, Shiuchi T, Okamoto S, Wakitani K, Minokoshi Y, Nakazato M. Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrainhypothalamic neural pathways in rats. Metabolism 61: 1312-1320, 2012.
54. Oldendorf WH. Blood-brain barrier permeability to peptides: pitfalls in measurement. Peptides 2, Suppl 2: 109-111, 1981.
55. Ono K, Asami R, Miyahara N, Nakanishi O, Inenaga K. Neuronal effects of neurokinin B on the rat subfornical organ. Neuroreport 22: 374-378, 2011.
56. Paxinos G, Watson D. The Rat Brain in Stereotaxic Coordinates. New York: Academic, 1982.
57. Price CJ, Rintoul GL, Baimbridge KG, Raymond LA. Inhibition of calcium-dependent NMDA receptor current rundown by calbindin-D28k. J Neurochem 72: 634-642, 1999.
58. Pulman KJ, Fry WM, Cottrell GT, Ferguson AV. The subfornical organ: a central target for circulating feeding signals. J Neurosci 26: 2022-2030, 2006.
59. Reeve JR Jr, Green GM, Chew P, Eysselein VE, and Keire DA. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Am J Physiol Gastrointest Liver Physiol 285: G255-G265, 2003.
60. Reeve JR Jr, Wu SV, Keire DA, Faull K, Chew P, Solomon TE, Green GM, Coskun T. Differential bile-pancreatic secretory effects of CCK-58 and CCK-8. Am J Physiol Gastrointest Liver Physiol 286: G395-G402, 2004.
61. Rehfeld JF. Four basic characteristics of the gastrin-cholecystokinin system. Am J Physiol Gastrointest Liver Physiol 240: G255-G266, 1981.
62. Reidelberger RD. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats. Am J Physiol Regul Integr Comp Physiol 263: R1354-R1358, 1992.
63. Reidelberger RD, Hernandez J, Fritzsch B, Hulce M. Abdominal vagal mediation of the satiety effects of CCK in rats. Am J Physiol Regul Integr Comp Physiol 286: R1005-R1012, 2004.
64. Riediger T, Rauch M, Schmid HA. Actions of amylin on subfornical organ neurons and on drinking behavior in rats. Am J Physiol Regul Integr Comp Physiol 276: R514-R521, 1999.
65. Rinaman L. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation. J Neurosci 23: 10084-10092, 2003.
66. Ritter RC, Ladenheim EE. Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin. Am J Physiol Regul Integr Comp Physiol 248: R501-R504, 1985.
67. Ritter RC, Malbasa Z. CCK-A receptor antagonist increases food intake in capsaicin-treated rats. Soc Neurosci Abstracts 21: 460, 1995.
68. Rowland NE, Goldstein BE, Robertson KL. Role of angiotensin in body fluid homeostasis of mice: fluid intake, plasma hormones, and brain Fos. Am J Physiol Regul Integr Comp Physiol 284: R1586-R1594, 2003.
69. Saavedra JM, Correa FM, Plunkett LM, Israel A, Kurihara M, Shigematsu K. Binding of angiotensin and atrial natriuretic peptide in brain of hypertensive rats. Nature 320: 758-760, 1986.
70. Sartor DM, Verberne AJ. Abdominal vagal signalling: a novel role for cholecystokinin in circulatory control? Brain Res Rev 59: 140-154, 2008.
71. Smith PM, Chambers AP, Price CJ, Ho W, Hopf C, Sharkey KA, Ferguson AV. The subfornical organ: a central nervous system site for actions of circulating leptin. Am J Physiol Regul Integr Comp Physiol 296: R512-R520, 2009.
72. Smith PM, Ferguson AV. Cardiovascular actions of leptin in the subfornical organ are abolished by diet-induced obesity. J Neuroendocrinol 24: 504-510, 2012.
73. Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state-central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol 299: R405-R415, 2010.
74. South EH, Ritter RC. Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety. Peptides 9: 601-612, 1988.
75. Srebro Z. Circumventricular organs: a self-regulating system. Folia Biol (Krakow) 16: 25-38, 1968.
76. Stengel A, Keire D, Goebel M, Evilevitch L, Wiggins B, Tache Y, Reeve JR Jr. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 150: 5113-5118, 2009.
77. Sun K, Ferguson AV. Cholecystokinin activates area postrema neurons in rat brain slices. Am J Physiol Regul Integr Comp Physiol 272: R1625-R1630, 1997.
78. Sunn N, Egli M, Burazin TC, Burns P, Colvill L, Davern P, Denton DA, Oldfield BJ, Weisinger RS, Rauch M, Schmid HA, McKinley MJ. Circulating relaxin acts on subfornical organ neurons to stimulate water drinking in the rat. Proc Natl Acad Sci USA 99: 1701-1706, 2002.
79. Sutton GM, Patterson LM, Berthoud HR. Extracellular signal-regulated kinase 1/2 signaling pathway in solitary nucleus mediates cholecystokinininduced suppression of food intake in rats. J Neurosci 24: 10240-10247, 2004.
80. Suzuki S, Ramos EJ, Goncalves CG, Chen C, Meguid MM. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery 138: 283-290, 2005.
81. van de Wall EH, Duffy P, Ritter RC. CCK enhances response to gastric distension by acting on capsaicin-insensitive vagal afferents. Am J Physiol Regul Integr Comp Physiol 289: R695-R703, 2005.
82. Wank SA. Cholecystokinin receptors. Am J Physiol Gastrointest Liver Physiol 269: G628-G646, 1995.
83. Weiland TJ, Voudouris NJ, Kent S. The role of CCK2 receptors in energy homeostasis: insights from the CCK2 receptor-deficient mouse. Physiol Behav 82: 471-476, 2004.
84. Williams JA, Sans MD, Tashiro M, Schafer C, Bragado MJ, Dabrowski A. Cholecystokinin activates a variety of intracellular signal transduction mechanisms in rodent pancreatic acinar cells. Pharmacol Toxicol 91: 297-303, 2002.
85. Woltman TA, Hulce M, Reidelberger RD. Relative blood-brain barrier permeabilities of the cholecystokinin receptor antagonists devazepide and A-65186 in rats. J Pharm Pharmacol 51: 917-920, 1999.
86. Young CN, Morgan DA, Butler SD, Mark AL, Davisson RL. The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension 61: 737-744, 2013.
87. Zhang J, Ritter RC. Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms. Am J Physiol Regul Integr Comp Physiol 302: R264-R273, 2012.
88. Zhao H, Simasko SM. Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons. Endocrinology 151: 5237-5246, 2010.
89. Zittel TT, Glatzle J, Kreis ME, Starlinger M, Eichner M, Raybould HE, Becker HD, Jehle EC. C-fos protein expression in the nucleus of the solitary tract correlates with cholecystokinin dose injected and food intake in rats. Brain Res 846: 1-11, 1999.